Back to results
US 2006/0142397 A1Published application
Use of a pparalpha agonist and metormin for decreasing the serum triglycerides
OwnerJean-Louis Junien, Alan Edgar +1inventors
InventorsJean-Louis Junien, Alan Edgar, Evelyne Chaput
Life of this patent
Estimating the term…
Abstract
The present invention relates to the combined use of a PPARα agonist and metformin for decreasing serum triglycerides.
Claims8
1-10. (canceled)
A method of treating obesity comprising co-administering to a patient in need thereof an effective dosage of a PPARα agonist and metformin.
Dependencies are inferred from the claim text.